ResMed | RMD

Stock Price
183.68
Daily Change
-0.40 -0.22%
Monthly
-4.98%
Yearly
-18.94%
Q2 Forecast
194.25
Peers Price Chg Day Year Date
ANN Ansell 25.30 -0.14 -0.55% -5.35% Apr/26
ATRC AtriCure 22.61 -0.41 -1.78% -46.49% Apr/25
BAX Baxter International 40.25 -0.73 -1.78% -12.65% Apr/25
COH Cochlear 320.77 0.78 0.24% 28.70% Apr/26
COO Cooper Companies 89.90 -0.35 -0.38% -5.12% Apr/25
CSL CSL 273.30 -5.15 -1.85% -10.10% Apr/26
DXCM Dexcom 138.02 0.04 0.03% 10.48% Apr/25
EW Edwards Lifesciences 87.89 -0.84 -0.94% 0.54% Apr/25
FPH Fisher Paykel Healthcare 27.40 -0.81 -2.87% 0.59% Apr/26
GMED Globus Medical 50.37 -1.07 -2.08% -12.64% Apr/25
HAE Haemonetics 87.66 1.44 1.67% 6.47% Apr/25
HOLX Hologic 75.71 -1.07 -1.39% -10.84% Apr/25
IART Integra LifeSciences 28.43 -0.95 -3.23% -47.55% Apr/25
IDXX Idexx Laboratories 489.40 -5.53 -1.12% 1.65% Apr/25
ISRG Intuitive Surgical 371.49 -2.02 -0.54% 25.95% Apr/25
MASI Masimo 135.35 -0.57 -0.42% -27.59% Apr/25
MDT Medtronic 79.06 -1.21 -1.50% -12.13% Apr/25
PHIA Philips 19.40 0.13 0.67% 1.22% Apr/26
PODD Insulet 164.03 -3.20 -1.91% -48.20% Apr/25
RHC Ramsay Health Care 51.46 -0.94 -1.79% -21.54% Apr/26
RMD ResMed 183.68 -0.40 -0.22% -18.94% Apr/25
SHL Sonic Healthcare 26.34 -0.40 -1.50% -26.18% Apr/26
SIG Sigma Healthcare 1.27 -0.03 -2.32% 79.43% Apr/26
STE Steris 201.54 -1.54 -0.76% 10.83% Apr/25
TFX Teleflex 206.12 -5.36 -2.53% -23.19% Apr/25
TMO Thermo Fisher Scientific 571.73 -6.35 -1.10% 7.24% Apr/25

Indexes Price Day Year Date
MID US400 2887 -13.99 -0.48% 18.79% Apr/25
SPX US500 5082 -23.21 -0.46% 22.90% Apr/26

ResMed traded at $183.68 this Thursday April 25th, decreasing $0.40 or 0.22 percent since the previous trading session. Looking back, over the last four weeks, ResMed lost 4.98 percent. Over the last 12 months, its price fell by 18.94 percent. Looking ahead, we forecast ResMed to be priced at 194.25 by the end of this quarter and at 183.33 in one year, according to Trading Economics global macro models projections and analysts expectations.

ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep apnea, chronic obstructive pulmonary disease (COPD), neuromuscular disease and other chronic diseases. The Company operates through two segments: Sleep and Respiratory Care segment, and the Software-as-a-Service (SaaS) segment. Sleep apnea includes obstructive sleep apnea and other respiratory disorders that occur during sleep. Its cloud-based digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes. The Company's portfolio of products includes ventilation devices, diagnostic products, mask systems, headgear and other accessories, dental devices, portable oxygen concentrators (POCs) and cloud-based software informatics solutions.